Resveratrol inhibits the secretion of vascular endothelial growth factor and subsequent proliferation in human leukemia U937 cells

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 27, Issue 5, 2007, Pages 508-512

  Tang, Zehai ^a   Liu, Xin Yue ^a   Zou, Ping ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Cell proliferation; Resveratrol; U937 leukemia cells; Vascular endothelial growth factor

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; RESVERATROL; STILBENE DERIVATIVE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL STRAIN U937; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION REGULATION; HUMAN; SECRETION;

ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; STILBENES; U937 CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 36849079838     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-007-0508-0     Document Type: Article

References (20)

1. Hain R, Bieseler B, Kindl H et al. Expression of a stilbene synthase gene in Nicotiana tabacum results in synthesis of the phytoalexin resveratrol. Plant Mol Biol, 1990,15:325-335
2. Corder R, Douthwaite J A, Lees D M et al. Endothelin-1 synthesis reduced by red wine. Nature, 2001,414:853-854
3. Jang M, Cai L, Udeani G O et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 1997,275(10):218-220
4. Aggarwal B B, Bhardwaj A, Aggarwal R S et al. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res, 2004,24:2783-2840
5. Estrov Z, Shishodia S, Faderl S et al. Resveratrol blocks interleukin-1 {beta}-induced activation of the nuclear transcription factor NF-{kappa}B, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood, 2003,102(3):987-995
6. Bhardwaj A, Sethi G, Vadhan-Raj S et al. Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-{kappa}B-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood, 2007,109(6):2293-2302
7. Joe A K, Liu H, Suzui M et al. Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin Cancer Res, 2002,8:893-903
8. Clement M V, Hirpara J L, Chawdhury S H et al. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood, 1998,92:996-1002
9. Folkman J. Angiogenesis and apoptosis. Semin Cancer Biol, 2003,13:159-167
10. Padró T, Ruiz S, Bieker R et al. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood, 2000,95:2637-2644
11. Fragoso R, Pereira T, Wu Y et al. VEGFR-1 (FLT-1) activation modulates acute lymphoblastic leukemia localization and survival within the bone marrow, determining the onset of extramedullary disease. Blood, 2006,107:1608-1616
12. Lin M T, Yen M L, Lin C Y et al. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Sre-dependent vascular endothelial cadherin tyrosine phosphorylation. Mol Pharmacol, 2003,64:1029-1036
13. Saijonmaa O, Nyman T, Kosonen R et al. Upregulation of angiotensin-converting enzyme by vascular endothelial growth factor. Am J Physiol Heart Circ Physiol, 2001,280:H885-H891
14. Gehm B D, McAndrews J M, Chien P Y et al. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist of the estrogen receptor. Proc Natl Acad Sci USA, 1997,94:14138-14143
15. Rodrigue C M, Arous N, Bachir D et al. Resveratrol, a natural dietary phytoalexin, possesses similar properties to hydroxyurea towards erythroid differentiation. Br J Haematol, 2001,113:500-507
16. Fujita M, Hayashi I, Yamashina S et al. Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth. Carcinogenesis. 2005,26(2):271-279
17. Dias S, Choy M, Alitalo K et al. VEGF(165) promotes survival of leukemic cells by Hsp90 mediated induction of Bcl-2 expression and apoptosis inhibition. Blood, 2002,99(6):2532-2540
18. Rodgers K E, Xiong S, Steer R et al. Effect of angiotensin II on hematopoietic progenitor cell proliferation. Stem Cells, 2000,18(4):287-294
19. Satoh C, Fukuda N, Hu W Y et al. Role of endogenous angiotensin in the increased expression of growth factors in vascular smooth muscle cells from spontaneously hypertensive rats. J Cardiovasc Pharmacol, 2001,37(1):108-118
20. Saijonmaa O, Nyman T, Kosonen R et al. Upregulation of angiotensin-converting enzyme by vascular endothelial growth factor. Am J Physiol Heart Circ Physiol, 2001,280(2):H885-H891